Drug Shortage Report for NEO-LARYNGOBIS
| Report ID | 195198 |
| Drug Identification Number | 00065927 |
| Brand name | NEO-LARYNGOBIS |
| Common or Proper name | NEO-LARYNGOBIS |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | BISMUTH DIPROPYLACETATE |
| Strength(s) | 135MG |
| Dosage form(s) | SUPPOSITORY |
| Route of administration | RECTAL RECTAL |
| Packaging size | 2 |
| ATC code | R02AA |
| ATC description | THROAT PREPARATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-06-16 |
| Estimated end date | 2023-09-30 |
| Actual end date | 2023-09-30 |
| Shortage status | Resolved |
| Updated date | 2023-10-03 |
| Company comments | OTC - Not reportable on DS |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v12 | 2023-10-03 | French | Compare |
| v11 | 2023-10-03 | English | Compare |
| v10 | 2023-08-17 | English | Compare |
| v9 | 2023-08-17 | French | Compare |
| v8 | 2023-08-17 | English | Compare |
| v7 | 2023-07-27 | French | Compare |
| v6 | 2023-07-27 | English | Compare |
| v5 | 2023-07-06 | French | Compare |
| v4 | 2023-07-06 | English | Compare |
| v3 | 2023-06-17 | English | Compare |
| v2 | 2023-06-16 | French | Compare |
| v1 | 2023-06-16 | English | Compare |
Showing 1 to 12 of 12